All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
FACTOCEL VIII 250IU INJECTION_1
FACTOCEL VIII 250IU INJECTION_2
FACTOCEL VIII 250IU INJECTION_1
21% Off

Factocel Viii 250IU Injection

Prescription Required

cold-chain

Salt Composition : Factor Viii

Manufacturer : INTAS PHARMACEUTICALS LTD

Origin of Medicine : India

MRP: 3931.29
Price :3096
You Save :835 (21%)

1 Vial(s)

Prepaid Only. Non-Returnable

Pincode
Delivery By -

Introduction to Factocel Viii 250iu Injection

Factocel VIII 250IU Injection is an antihemophilic medicine in the class of miscellaneous coagulation modifiers containing the active ingredient Factor VIII. It is used to treat and prevent bleeding in individuals with hemophilia A, a genetic disorder caused by a deficiency or dysfunction of factor VIII, a clotting protein in the blood.

This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its component. Stop taking this tablet and contact your doctor immediately if you develop a rash or skin symptoms. The use of this drug increases the cardiovascular risk. It is highly advised to discuss with your physician if you have any existing heart disease condition before initiating the treatment with Factocel VIII 250IU Injection. A central venous access device (CVAD) may sometimes be required to administer this drug treatment. It's important to consider the risks associated with CVAD-related complications, including local infections, bacteremia (bacterial infection in the bloodstream), and catheter site thrombosis (blood clot formation at the catheter site). Proper care and monitoring should be exercised to minimize these risks. 

The development of inhibitors (antibodies) is a known complication that can occur during treatment with this medicine. These inhibitors can interfere with the effectiveness of the treatment. Patients receiving Factocel VIII 250IU Injection therapy should be closely monitored for the development of inhibitors. If bleeding is uncontrolled with this drug, you must notify your doctor immediately. If you are pregnant or breastfeeding, consult your doctor for more advice before starting the treatment with this drug.


Uses of Factocel Viii 250iu Injection

  • Treatment of Hemophilia A

Therapeutic Effects of Factocel Viii 250iu Injection

By facilitating the clotting process, Factocel VIII 250IU Injection helps prevent and control bleeding episodes in individuals with hemophilia A and other conditions associated with low factor VIII levels. It reduces the chance of complications such as bleeding, excessive blood loss, and related health issues.


Interaction of Factocel Viii 250iu Injection with other drugs

Inform your physician about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Factocel VIII 250IU Injection and cause undesirable side effects.


More Information about Factocel Viii 250iu Injection

  • Store Factocel VIII 250IU Injection in the refrigerator at (2°C to 8°C).
  • Do not freeze.

How to consume Factocel Viii 250iu Injection

Factocel VIII 250IU Injection is usually administered through a vein (intravenously) by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Do not self-administer this injection.


Safety Advices for Factocel Viii 250iu Injection

Image Not Available  

Pregnancy

  

If you are pregnant, suspecting, or planning for the pregnancy, ask your doctor for more advice before starting the treatment with Factocel VIII 250IU Injection. 

Image Not Available  

Breast Feeding

  

If breastfeeding, consult your doctor before starting the treatment with Factocel VIII 250IU Injection.

Image Not Available  

Lungs

  

It is unknown whether Factocel VIII 250IU Injection is safe for patients with lung problems. Notify your doctor if you have lung disease before starting the treatment.

Image Not Available  

Liver

  

It is unknown whether Factocel VIII 250IU Injection is safe for patients with liver problems. Inform your doctor if you have the liver disease before starting the treatment.

Image Not Available  

Alcohol

  

It is unknown whether consuming alcohol while taking Factocel VIII 250IU Injection is safe. Please speak with your physician.

Image Not Available  

Driving

  

Factocel VIII 250IU Injection does not affect your ability to drive and operate heavy machinery. Inform your physician if you face any symptoms that alter your concentration.


Side Effects of Factocel Viii 250iu Injection

Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.

Serious

  • Allergic reaction (anaphylactic shock) or a hypersensitivity reaction

Common

  • Reddening of the skin
  • Burning and stinging at the injection site
  • Chills
  • Flushing
  • Headache
  • Hives
  • Hypotension
  • Lethargy
  • Nausea
  • Restlessness
  • Tachycardia
  • Tightness of the chest
  • Tingling
  • Vomiting
  • Wheezing

Word of Advice

If you regularly or repeatedly receive human plasma-derived Factocel VIII 250IU Injection products, your doctor may recommend vaccination against hepatitis A and B. It is because there is a possible risk of exposure to these viruses through plasma-derived products. Vaccination can help protect against these infections.

Good dental hygiene is important to maintain oral health and prevent tooth and gum disease. It is particularly relevant for individuals with bleeding disorders such as hemophilia A, as they may be more susceptible to excessive bleeding. If you notice any changes in your symptoms or have concerns about the treatment with Factocel VIII 250IU Injection, immediately communicate them to your physician for more advice.


FAQs

Q 1. Is Factocel VIII 250IU Injection derived from human plasma or produced through recombinant DNA technology?

Factocel VIII 250IU Injection can be derived from human plasma, which undergoes a purification process or is produced using recombinant DNA technology

Q 2. Can Factocel VIII 250IU Injection be used in children?

Yes, Factocel VIII 250IU Injection can be used in children. The dosage and administration may vary based on the child's age, weight, and needs. Pediatric patients with hemophilia A can benefit from regular treatment with this drug to prevent and manage bleeding episodes.

Q 3. Are there any potential side effects of Factocel VIII 250IU Injection?

The most common side effect of Factocel VIII 250IU Injection is the development of inhibitors (antibodies) that can interfere with the effectiveness of the treatment. Other possible side effects include allergic reactions, infusion site reactions, and the risk of blood clots.

Q 4. How is Factocel VIII 250IU Injection administered?

Factocel VIII 250IU Injection is administered intravenously (IV) through a needle inserted into a vein by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

Q 5. Can Factocel VIII 250IU Injection be used during surgery or dental procedures?

Factocel VIII 250IU Injection can be used before surgery or dental procedures in individuals with hemophilia A to prevent excessive bleeding. Coordinating with the healthcare team is important to ensure proper dosing and timing.


Fact Box of Factocel Viii 250iu Injection

Molecule Name: Factor VIII 

Therapeutic class:  Antihemophilic agents

Pharmacological class: Miscellaneous coagulation modifiers

Indications: Treatment of Hemophilia A


References

  1. Biotest Pharma GmbH, Electronic Medicines Compendium (EMC), [Revised on Dec 2022], [Accessed on 01 July 2023], Available at: https://www.medicines.org.uk/emc/files/pil.579.pdf.
  2. Baxter Healthcare Corporation- food and drug administration (FDA), [Accessed on 01 July 2023] Available at: https://www.fda.gov/media/78280/download#:~:text=Factor%20VIII%20is%20the%20specific,spontaneously%20or%20after%20minor%20trauma.
  3. KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting coagulation, bleeding, and thrombosis, 7th edition, 2013, 217.

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.